Serum Cytokeratin 19 Fragment, CK19-2G2, as a Newly Identified Biomarker for Lung Cancer

Jia Gao, Fang Lv, Jia Li, Zongyong Wu, Jun Qi

PLoS ONE · 2014 · 11 citations · 8 references

DOIFull text

Open access

Abstract

CK19-2G2 may be a candidate marker for diagnosing and monitoring a patient's response to lung cancer treatment. In addition, CK19-2G2 may be an indicator for micrometastases in lung cancer patients.

References

8